Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare variant of undifferentiated pancreatic carcinoma characterized by the presence of non-neoplastic osteoclast-like giant cells.
Biomarker and diagnostic research for undifferentiated pancreatic carcinoma with osteoclast-like giant cells has been reported in the published literature.
No clinical trials have been registered for undifferentiated pancreatic carcinoma with osteoclast-like giant cells.
19 publications have been identified in PubMed for undifferentiated pancreatic carcinoma with osteoclast-like giant cells. Research spans Case Report / Case Series (47%), Review / Meta-Analysis (32%), and Epidemiology / Natural History (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 47% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:49 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
6 |
32% |
Disease patterns and progression | 2 | 11% |
Testing and diagnosis research | 1 | 5% |
Laboratory research | 1 | 5% |
Reagan AM (2026). [PMID: 41669110](https://pubmed.ncbi.nlm.nih.gov/41669110/). *Front Oncol*. [Case Report / Case Series]
Chang E (2026). [PMID: 42121938](https://pubmed.ncbi.nlm.nih.gov/42121938/). *Cells*. [Review / Meta-Analysis]
Bhandari N (2026). [PMID: 40924630](https://pubmed.ncbi.nlm.nih.gov/40924630/). *Int J Surg Pathol*. [Case Report / Case Series]
Huang J (2026). [PMID: 41939768](https://pubmed.ncbi.nlm.nih.gov/41939768/). *Front Med (Lausanne)*. [Case Report / Case Series]
Sonoda I (2025). [PMID: 41158702](https://pubmed.ncbi.nlm.nih.gov/41158702/). *Mol Clin Oncol*. [Epidemiology / Natural History]
Yonghao O (2025). [PMID: 40347088](https://pubmed.ncbi.nlm.nih.gov/40347088/). *Cancer Med*. [Review / Meta-Analysis]
Gayibov E (2025). [PMID: 40115925](https://pubmed.ncbi.nlm.nih.gov/40115925/). *J Gastrointest Oncol*. [Review / Meta-Analysis]
Takahashi Y (2025). [PMID: 40230762](https://pubmed.ncbi.nlm.nih.gov/40230762/). *Cureus*. [Case Report / Case Series]
Si L (2025). [PMID: 40755479](https://pubmed.ncbi.nlm.nih.gov/40755479/). *Front Surg*. [Case Report / Case Series]
Luo W (2025). [PMID: 41198503](https://pubmed.ncbi.nlm.nih.gov/41198503/). *Pancreatology*. [Diagnostic / Biomarker]